Friday, July 21, 2017

Blood tests may help to create personalized treatments for advanced prostate cancer

Blood tests may help to create personalized treatments for advanced prostate cancer

A simple blood test helps devise a personalized treatment for men with advanced prostate cancer.

The new test costs less than 50 pounds, can predict which patients are likely to respond to new targeted drugs and who can better cope with alternative therapies.

It looks for multiple copies of the androgen receptor gene, which is a hormone-sensitive molecule that helps the growth of many prostate cancers.

Men with multiple copies of this gene did not respond very well to avilaterone and enzartamide drugs used in the treatment of advanced prostate cancer.
This drug is given to men who began spreading, cancer no longer responds to traditional hormonal therapy.

"Abraterone and enzaltamide are excellent treatments for advanced prostate cancer, and some men can take these drugs for years, cancer.

"But in other men these drugs do not work well and the disease returns rapidly.Actually, licensed exams for the doctor to choose whether these are the best treatment for individuals There is none.
"We select a male with advanced prostate cancer who is more likely to respond to Aviraterone and Enzaltamide and choose a robust clinic that can be used in a clinic to select a male who may need alternative treatment We developed a test.

"Our method is less than 50 pounds and can provide results quickly and can be carried out at NHS hospital laboratories to evaluate this trial in a future clinical trial and evaluate one of the standard patient care I hope to become a department.

In this study published in Annals of Oncology, blood samples from patients participating in three different clinical trials were taken.

In the initial study of 171 patients, men found to have multiple copies of the androgen receptor gene had a 4-fold higher mortality rate than those who had negative test results.
Men with multiple copies of 94 second group genes responded to avilaterone and enzaltamide 8 fold shorter than animals with 1 or 2 copies.

It has already been known that the androgen receptor plays an important role in cancers resistant to the two drugs.

Dr. Ian Frame, Director of Research for UK Prostate Cancer, who funded the study, said, "In order to stop prostate cancer from dying, it is necessary to treat all treatments as one.

"This test will be an important step toward that, we are closely watching the development"
Dr. Emma Smith of Cancer Research UK (which contributed to financing) said, "If it is further confirmed that this exam is reliable, for men who prostate cancer may not respond to standard treatment,

Every year about 41,000 men in the UK are diagnosed with prostate cancer and 11,000 have died of this disease.

Promising results with prostate cancer

Promising results with prostate cancer

Expanding the lives of many men developing prostate cancer ...

By combining two existing prostate cancer therapies, studies published at the world's largest cancer conference can extend the life of men with progressive high-risk prostate cancer by 37%. New findings may change how the doctor approaches first to treat prostate cancer.
"These are the most powerful results from prostate cancer trials," said Nicholas James, the foremost author of the American Society of Clinical Oncology. "This is a single sense of career, which is one of the greatest deaths I have seen in adult cancer clinical trials.

Researchers used standard hormone therapy and a drug called Aviraterone. Aviraterone is normally only used for cancer patients who no longer respond to hormone therapy. This study was conducted as part of the Stampede Test, an ongoing randomized trial conducted in the UK and Switzerland.

"Abilateron not only prolongs life but also reduces the likelihood of recurrence by 70% and reduces the probability of serious bone complications by 50%," James said. "Based on the magnitude of the clinical benefit, the prospective care of newly diagnosed patients with advanced prostate cancer should change," he said.

In this study, 2,000 men gathered. Patients who received both aviraterone and normal hormone therapy had significantly lower mortality than those who received hormonal therapy alone.
Relatively, 83% of men who received avilateron therapy survived 76% of men with standard hormone therapy. Researchers also discovered that patients taking both medications were particularly somewhat stronger in cardiovascular and liver side effects.

One patient, Alfred Samuels (59 years old) who participated in this study, was diagnosed with prostate cancer progressed in January 2012. "I felt my world weakened all night," the doctor explained, "Since surgery spread across the prostate gland, surgery is not my option.

"As part of the trial, I began taking Avilaterone four times a day and received hormonal injections every eight weeks. When I conducted an examination in the first 6 months I was shown that the treatment was effective I am still in trial.I am relieved.Fortunately, my cancer is well managed.

According to the Center for Disease Control and Prevention (CDC), more than 27,000 prostate cancer patients in the UK died each year in the U.S. More than 11,000 people die in the UK each year. In the United States, besides skin cancer, it is the most common cancer in men.

"The potential benefits of combining avilaterone and hormonal therapy are obviously impressive and will cooperate with relevant agencies so that these men will be able to select this treatment through NHS," prostate cancer UK .

Advances in prostate cancer surgery in New Zealand

Advances in prostate cancer surgery in New Zealand

New Zealand's Kasseln Kilgure Center (KKC) has treated the first patient of Augmenix's SpaceOAR system. This is a medical device that protects men from rectal complications after radiation therapy of prostate cancer.

As the prostate and rectum are anatomically adjacent, radiotherapy targeting the prostate may damage the rectum and cause pain, discomfort or diarrhea.

The SpaceOAR system works by injecting the hydrogel into the space between the prostate and the rectum and produces a force to push the organs away from one another. As a result, during prostate radiation therapy, the rectum is out of the area affected by radiation and is less damaged.
Dr. Leanne Tyrie, clinical director of KKC, said, "KKC is dedicated to providing the best care for patients, and the introduction of SpaceOAR hydrogels for prostate cancer males is no longer necessary to achieve this It is one step. " "Significant reductions in intestinal, urinary and sexual side effects after radiation therapy using SpaceOAR hydrogel have decided to incorporate it as part of the criteria for caring for prostate cancer patients."

In addition to increasing rectal protection, hydrogels can also reduce radiation and harmful side effects to urine and genitals.

The hydrogel keeps the interval for 3 months, gradually becomes liquid and is excreted in urine by kidney filtration for about 6 months after injection.

"According to recent clinical data, SpaceOAR hydrogels have been shown to be helpful in significantly reducing the risk of side effects of rectal and side effects and loss of sexual function associated with radiation therapy in the treatment of prostate cancer," Augmenix CEO John Pedersen said. "The first patient treated with New Zealand's SpaceOAR hydrogel is proud to offer treatment for high quality, multi-modality radiation therapy for men who have been diagnosed with prostate cancer. At the Kathleen Kilgour Center I am glad that I was.

Augemix, based in Bedford, Massachusetts, evaluates the safety of male systems undergoing image induced intensity modulated radiation therapy (IG-IMRT) and evaluates whether it is using SpaceOAR hydrogel weight loss exposure For phase III clinical trials in the US (NCT 0 055 6, 628) exposure to the rectum.

The results showed that the hydrogel spacer is safe and tolerable. It decreased the report of pain during treatment and significantly reduced rectal radiation injury. One year after radiotherapy, the rectal complications decreased by 71%, and those who did not inject hydrogel had 3.5 times the incidence of rectal complications.

Three years after treatment, patients treated with SpaceOAR had reduced rectal radiation dose by 73.5% and improved urinary function and sexual function.

Men who received SpaceOAR are eight times less likely to experience a marked decline in quality of life, 78% of men who were sexually active before receiving SpaceOAR treatment may retain sexual function in 3 years Was high.

Thursday, July 20, 2017

Abdominal abnormal cancer

Abdominal abnormal cancer

  • Adrenal cortical carcinoma
  • Stomach (cancer) cancer
  • Pancreatic cancer
  • Colorectal cancer
  • Neuroendocrine tumor (carcinoid tumor)
  • Gastrointestinal stromal tumor
Adrenal cortical carcinoma

There are two adrenal glands. The adrenal gland is small, shaped like a triangle. One adrenal gland sits on each kidney. Each adrenal gland has two parts. The outer layer of the adrenal gland is the adrenal cortex. The adrenal gland is the adrenal medulla. Adrenal cortical cancer is also called adrenal cortex cancer.

Childhood adrenocortical carcinoma is the most common in patients under the age of 6 or under 10, often in females.

The adrenal cortex makes important hormones such as:

  • We will balance water and salt in the body.
  • It helps maintain blood pressure properly.
  • Controls the use of body proteins, fats, carbohydrates.
  • The body has male or female characteristics.

Risk factors, signs and symptoms, and diagnostic and staging examination

The risk of adrenocortical cancer is increased by having mutations (changes) in either the gene or the following syndromes:

  • Li-Fraumeni syndrome.
  • Beckwith-Wiedemann syndrome.
  • Hypertrophy

Tumors of the adrenal cortex may function (make more hormones than normal) or do not function (do not make extra hormones). Most tumors of adrenal cortex in children are functional tumors. Extra hormones made by functioning tumors cause specific signs or symptoms of disease, which depend on the type of hormone made by the tumor. For example, extra androgen hormones can develop male characteristics such as body hair or voice to both male and female children, grow faster and cause acne. Extra estrogen hormones can cause the growth of breast tissue in male children. (For details of signs and symptoms of adrenal cortical cancer see the PDQ summary on Adult Adrenocortical Cancer Treatment).

The tests and treatments used for diagnosis and progression of adrenal cortical cancer depend on the symptoms of the patient. They may include the following:

  • Physical examination and history.
  • Blood chemistry research.
  • X-ray of chest, abdomen, bone.
  • CT scan.
  • MRI.
  • PET scan.
  • Biopsy (mass is removed during surgery and then examined for signs of cancer).

For a description of these tests and procedures, see the General Information section.

Other tests used to diagnose adrenal cortical cancer include the following:

24 hour urine test: a test in which urine is collected for 24 hours and the amount of cortisol or 17-ketosteroid is measured. An amount higher than the normal amount of these substances in urine can be a sign of disease in the adrenal cortex.

Low-dose dexamethasone suppression test: a study in which one or more small doses of dexamethasone are administered. Levels of cortisol are checked from blood samples or urine collected for 3 days. We will do this to see if the adrenal glands produce excessive cortisol.

High dose dexamethasone suppression test: a study in which dexamethasone is administered at a high dose one or more times. Levels of cortisol are checked from blood samples or urine collected for 3 days. This test is done to see if the adrenal glands are producing excessive cortisol or that the pituitary secretes excessive cortisol in the adrenal glands.

Blood hormone study: a procedure to check a blood sample to determine the amount of a particular hormone released into the blood from organs and tissues in the body. An abnormal (usually higher or lower) amount of a substance can be a sign of disease in an organ or tissue that brings about it. Blood can be tested for testosterone or estrogen. An amount greater than the normal amount of these hormones may be a sign of adrenocortical cancer.

Adrenal angiogram: a procedure for viewing the arterial and blood flow near the adrenal glands. A contrast medium is injected into the adrenal artery. As the dye moves through the blood vessel, a series of X-rays examines whether the artery is blocked.

Adrenal venography: procedures for viewing the adrenal glands and blood flow near the adrenal glands. A contrast medium is injected into the adrenal gland. As the contrast agent moves through the vein, a series of X-rays are taken to see if the vein is occluded. Insert a catheter (a very thin tube) into a vein, collect a blood sample and check for abnormal hormone levels.

Prognosis

Prognosis (probability of recovery) is suitable for patients with small tumors completely resected by surgery. For other patients, the prognosis depends on:

  • The age of the child.
  • Size of the tumor.
  • Whether the child developed masculine characteristics.
  • Whether the coating around the tumor was opened during surgery to remove the tumor.

These tumors may spread to the kidneys, lungs, bones, and the brain.

Processing

Treatment of adrenal cortical cancer in children includes the following:

Surgery to resect the tumor with or without chemotherapy.
See the PDQ summary on Adult Adrenocortical Cancer Treatment for details.

Stomach (cancer) cancer

Gastric cancer is a disease in which malignant (cancer) cells are formed in the inner layer of the stomach. The stomach is a J-shaped organ in the upper abdomen. It is part of the gastrointestinal system that helps treat and release nutrients (vitamins, minerals, carbohydrates, fats, proteins, water) contained in foods to the outside of the body. Food moves from the throat to the stomach through a tube of a hollow muscle called the esophagus. When you leave your stomach, partially digested food enters the small intestine and enters the large intestine.

The esophagus and stomach are part of the upper gastrointestinal (gastrointestinal) system.

The risk of gastric cancer is increased by infection with Helicobacter pylori bacteria found in the stomach.

Symptoms and symptoms

Many patients have anemia (less than the normal number of erythrocytes), but there are no signs or symptoms before spreading the cancer. Gastric cancer can cause either of the following signs and symptoms: Please check with your child's doctor whether your child has one of the following:

  • Stomach pain.
  • Lack of appetite.
  • Weight loss due to why nothing is known.
  • nausea.
  • vomiting.
  • Constipation or diarrhea
  • weakness.

Other symptoms that are not gastric can cause these same signs and symptoms.

Diagnostic test and staging test

Tests for diagnosing and staging gastric cancer include the following:

  • Physical examination and history.
  • Abdominal X - ray.
  • Blood chemistry research.
  • CT scan.
  • biopsy.

For a description of these tests and procedures, see the General Information section.

Other tests used to diagnose gastric cancer include the following:

Upper endoscope: Procedure to examine the abnormal area by examining the esophagus, stomach, and duodenum (the first part of the small intestine). The endoscope passes through the mouth and passes the throat through the esophagus. The endoscope is a thin tube-like instrument and can see the light and the lens. There may also be tools under the microscope to remove tissue or lymph node samples to check for signs of disease.

Barium swallowing: a series of x-rays of esophagus and stomach. The patient drinks liquid containing barium (silver white metal compound). Liquid covers the esophagus and stomach and X-rays are taken. This procedure is also called the top GI series.

Complete hemocyte count (CBC): Procedure to take a blood sample and perform the following inspection.

  • Number of red blood cells, white blood cells, platelets.
  • Amount of hemoglobin (protein carrying oxygen) in erythrocytes.
  • Part of the blood sample consisting of erythrocytes.

Prognosis

Prognosis (opportunity for recovery) depends on whether cancer is spreading during diagnosis.

Processing

The treatment of gastric cancer in children includes the following:

  • Surgery to remove healthy tissue around the cancer and its surroundings.
  • Surgery to remove as much cancer as possible, followed by radiotherapy and / or chemotherapy.
  • For details, refer to the PDQ summary on adult stomach cancer treatment.

Pancreatic cancer

Pancreatic cancer is a disease in which malignant (cancer) cells are located in pancreatic tissues. The pancreas is a pear-shaped gland about 6 inches. The wide end of the pancreas, the central part of the body is called is called, the tight end. Many different types of tumors can be established in the pancreas. Some tumors are benign (not cancer).
Anatomy of the pancreas. The pancreas has three areas: the head, the torso and the tail. It is found in the abdomen near the abdomen, the intestine, and other organs.
There are two main jobs in the body of the pancreas:


  • These juices are secreted in the small intestine, which help in the preparation of juice.
  • These hormones are secreted in blood to form hormones that help control the sugar and salt levels in the blood.

There are four types of pancreatic cancer in children:

Pancreatic congestive tumor of the pancreas is the most common type of pancreatic tumor, it affects both teenagers and young adults of the highest age group of tumors, both of which are cell-like and concrete. Pancreatic congestive tumors of the pancreas are not likely to spread in other parts of the body and prognosis is very good.

Pancreatoblastoma It usually occurs in children under 10 years of age or less, with children with Beckwith-Wiedeman's syndrome and family adenomatous polyposis (FAP) syndrome have increased the risk of developing penicibilablastoma. These tumors can make adrenocorticotropic hormone (ACH) and antidiurectic hormone (ADH). Pancetioblastoma can spread to the liver, lung, and lymph nodes. Diagnosis of disease for children with pancreabblomostoma is good.

Islet Cell Tumors These tumors are not common in children and can be benign or malignant. Islet cell tumors can occur in children with many endocrine neoplasia type 1 (MEN1) syndrome. The most common type of islet cell tumor is insulinoma and gastrinoma. These tumors can make hormones, such as insulin and gastrin, which can lead to symptoms and symptoms.
Pancreatic carcinoma is very rare in pancreatic carcinoma children. There are two types of pancreatic carcinoma: Acetyl cell carcinoma and Ductal adenocarcinoma.

Signs and symptoms

In children, some pancreatic tumors do not hide hormones and do not have signs and symptoms of the disease. This makes it difficult to diagnose pancreatic cancer.

Pancreatic tumors that wrap the hormones, can cause symptoms and symptoms. Symptoms and symptoms depend on the type of hormone.

If the tumor secretes insulin, there may be signs and symptoms that include:

  • low blood sugar. From this, you can feel blurred vision, headache, and light, tired, weak, unstable, nervous, irritable, sweaty, confused or hungry.
  • Change in behavior
  • Seizure
  • Coma.

If the tumor secretes gastrines, there may be signs and symptoms that include

  • Stomach ulcers which keep coming back
  • Pain in the stomach, which can spread on the back, can cause pain and it can go away after carrying an antacid.
  • Flow of stomach contents back into the esophagus (gastroosophageal reflux)
  • Diarrhea

Due to other types of hormones that cause tumors, symptoms and symptoms may include:

  • watery diarrhea.
  • Dehydration (feeling thirsty, less urine, dry skin and mouth, headache, dizziness, or fatigue)
  • Lower sodium (salt) levels (delusions, sleep, muscle weakness, and seizures) in the blood.
  • Weight loss or gain for a known cause
  • Round faces and thin hands and feet
  • Feeling very tired and weak
  • high blood pressure.
  • Purple or pink stretch marks on the skin.

If the cancer is in the head of the pancreas, the water vessel or blood flow in the stomach can be blocked and the following symptoms can be:

  • Jaundice (yellow skin of eyes and white)
  • Blood in stool or vomiting

If you see any of these problems in your child, then check with your child's doctor. Other conditions which are not pancreatic cancer can be the cause of these symptoms and symptoms.

Clinical and Staging Tests

Test for diagnosis and condition of pancreatic cancer may include:

  • Physical examination and history
  • chest X-ray
  • CT scan.
  • MRI
  • pet scan.
  • Biopsy

See general information section for details of these tests and procedures

Other tests used to diagnose pancreatic cancer include:

Endoscopic ultrasound (EUS): an endoscope, which is a process usually through the mouth or rectum, is inserted into the body. A lens for viewing device and a thin, tube with endoscope light. At the end of the endoscope, a probe is used for high-energy sound waves to bounce off internal tissues or organs and apos (ultrasound). Echoes, a picture of body tissues called a sonogram This process is also called endoscience.

Endoscopic Retrograde Cholangioparagrastrophy (ERCP): A procedure used in X-rays is tubules that carry the liver from the liver to the hives of the bile and from the top of the bile to the small intestine. Sometimes the cause of pancreatic cancer causes these ducts narrow and block or slow down the flow of the bile, which causes jaundice. An endoscope (a thin, light tube) is passed in the first part of the small intestine with mouth, esophagus and stomach. A catheter (a small tube) is then inserted through the endoscope in the pancreatic ducts. A dye is injected into the tubes through the catheter and the x-ray is taken. If the ducts are blocked by a tumor, then a good tube can be inserted in the duct to block it. This tube, which is called a stent, can be left in place to keep the canal open. Tissue samples can also be taken under a microscope for cancer symptoms.

Smemetostatin receptor scantigraphy: A type of radionuclide scan is used to find pancreatic tumors. A very small amount of radioactive octroitide (a hormone which connects carcinoid tumors) is injected into the vein and travels through blood flow. Radioactive connects the octorotic tumor and a special camera that detects where radioactivity is used in the body from where the tumor is used. This process is used to diagnose islet cell tumors.

Laparoscopy: A surgical procedure to look for organs inside the stomach to check the symptoms of stomach. The small incisions (cuts) are made in the stomach wall and a laparoscope (a thin, illuminated tube) is inserted into one of the incisions. For the symptoms of diseases, to remove the organs under the microscope or to take the tissue samples, to run the processes, to insert other equipment through other or other incisions.

Laparotami: A surgical procedure in which an incision (cut) is made in the stomach wall, which can be examined inside the stomach for symptoms of the disease. The size of the incision depends on the reason why it is being leopardized. Sometimes the organs are removed or the tissue samples for the symptoms of the disease are taken under a microscope.

Treatment

Treatment of congenital congenital tumors of the pancreas in children can include:

  • Surgery for Tumor Removal
  • Chemotherapy for tumors which can not be removed by surgery or can spread to other parts of the body.

Treatment of pancreatioblastoma in children may include:


  • Surgery to remove tumor may be a strange process for the tumor in the head of the pancreas
  • Chemotherapy can be given to reduce tumors before surgery, more chemotherapy after surgery, for more tumor, tumors, which can not be removed from surgery, and tumors that have spread to other parts of the body. May be.
  • Chemotherapy can be given if the tumor does not respond to treatment or comes back
In the treatment of islet cell tumors in children, medication may include hormones and medicines for the following reasons:
  • Surgery for Tumor Removal
  • Chemotherapy and targeted therapy for tumors which can not be removed by surgery or which have spread to other parts of the body

For more information on pancreatic tumors, see the treatment for adult pancreatic cancer and the PDQ summary on adult pancreatic neuronDocorin tumor (islet cell tumor).

Colorectal Cancer

Colorectal cancer is a disease in which the fatal (cancerous) cells are in colon tissues or rectum, the colon is part of the digestive system of the body. The digestive system removes nutrients (vitamins, minerals, carbohydrates, fats, proteins and water) from foods and processes and helps in the removal of waste material outside the body. The digestive system is made up of the esophagus, stomach, and small and large intestines. The colon (the large intestine) is the first part of the large intestine and is about 5 feet long. Together, the rectum and rectal canal form the last part of the large intestine and are 6-8 inches long, the anal canal (opening of the large intestine outside the body) on the anus.


Showing anatomy, colon and other organs of less digestive tract
Risk Factors, Symptoms and Symptoms, and Clinical and Staging Tests

Childhood colorectal cancer may be part of a inherited syndrome. Some colorectal cancer is associated with a gene mutation in youth, which causes polyves (an increase in mucous membranes which is the colon line) which can later turn into cancer.

The risk of colorectal cancer increases with some inherited conditions, such as:

  • Victim familial adenomatosis polyposis
  • Familyial adenomatous polyposis (FAP)
  • Lynch syndrome
  • Li-Fraumeni syndrome
  • MYH-related polyposis
  • Turkic syndrome
  • Cowden syndrome
  • Teen polyps syndrome
  • Peugeot-liver syndrome

Those who are distributed among children who do not have inherited syndrome are not related to the risk of cancer.
Symptoms and symptoms of childhood coloretatal cancer usually depend on the forms of tumor. Colorectal cancer may be due to any of the following symptoms and symptoms: If your child has any of the following, contact your child's doctor.

Tumor of the rectum or lower colon may cause pain in stomach, constipation or diarrhea.
On the left side of the body, the colon may have a tumor:
A lump in the stomach
Weight loss for any known cause
nausea and vomiting.
loss of appetite.
Blood in the stool
Anemia (feeling tired, dizziness, fast or irregular heartbeats, shortness of breath, yellow skin)
Other conditions which are not colorectal cancers can be the reason for these symptoms and symptoms.

Tests for diagnosis and stage colorectal cancer may include:

Physical examination and history
chest X-ray
CT scan of chest, stomach and pelvic
pet scan.
MRI
bone scan.
Biopsy
Other tests used for the diagnosis of colorectal cancer include the following:

Colonoscopy: A process of viewing inside the rectum and colon to polyps, abnormal areas, or cancer. A colonoscope is placed through the rectum in the colon. A colonization is a thin, light like a tube and a lens for viewing. There may also be a tool to remove the clumps or tissue samples, which are checked under the microscope for cancer symptoms.
Barium enema: A series of X-rays in the lower gastrointestinal tract. A fluid in which barium (a silver-white metal compound) is inserted into the rectum, barium coats take low gastrointestinal tract and X-rays. This process is also called a lower GI series.
Falcel Maptit Blood Test: A test to check the stool (solid waste) for blood, which can be seen only with the microscope, small samples of stool are kept on special card and come back to the doctor or lab for testing .
Full Blood Count (CBC): A process in which a sample of blood has been prepared and checked for:
Number of red blood cells, white blood cells, and platelets
Hemoglobin (protein which takes oxygen) in red blood cells
Part of blood sample made of red blood cells
Kidney Function Test: A test that examines blood or urine samples for some amount of urine released by the urine. The normal amount of a substance can be more or less than one sign that the kidneys should do the same way, they are not working. It is also called a kidney function test.
Liver function test: A blood test to measure blood levels of some substances released by the liver. A high or low level of some substances can be a sign of liver disease.
Carcinombrionic Antigen (CEA) Assay: A test that measures the CEA level in the blood, the CEA is left in the blood from both cancer cells and normal cells. When found more than the normal amount, it may be indicative of colorectal cancer or other conditions
Diagnosis of disease

Diagnosis of disease (probability of recovery) depends on:

Whether the whole tumor was removed from surgery or not
Does the cancer spread to other parts of the body, such as lymph nodes, liver, pelvis, or ovary
treatment

Treatment for colorectal cancer in children may include:

Surgery to remove the tumor when it has not spread.
Radiation therapy and cammothery for tumors in the lower abdomen or lower abdomen
Combination chemotherapy
It can be treated with children with some family colorectal cancer syndrome:

Surgery to remove the colon before the forms of cancer.
The drug to decrease the number of particles in the colon.
For more information about adult cancer see the following PDQ summary:

  • Colon cancer treatment
  • Rectal cancer treatment
  • Neurouondroclin tumor (carcinoid tumor)

Neuroendocrine tumors (including carcinoid tumors) are usually in the belly or intestinal lining, but they can be made in other organs such as pancreatitis, lungs, or liver. These tumors are usually small, growing slowly, and benign (not cancerous). Some neurondroclin tumors are deadly (cancer) and spread to other places in the body. Occasionally in children, the neurorendrocrine tumor supplements (a sac that sticks to the first part of the large intestine near the end of the small intestine) occur. Tumors are often found during the surgery to remove the addendum.

For information about bronchial carcinoid tumors, see the Bronchial Tumor section of this summary.

Signs and symptoms

Some neuronocrin releases tumor hormones and other substances. If the tumor is in the liver, then high levels of these hormones can remain in the body and can cause a group of symptoms and symptoms called carcinoid syndrome. Due to the hormone somatostatin, carcinid syndrome can cause any of the following symptoms and symptoms. If your child has any of the following, contact your child's doctor.

Craving and feeling a hot in the face and neck
A fast heartbeat
Difficulty breathing.
Sudden drop in blood pressure (discomfort, confusion, weakness, dizziness, and yellowish, calm and sticky skin)
Diarrhea
Other conditions which are not neuroendrequire tumors can cause these symptoms and symptoms.

Clinical and Staging Tests

The test that tests the symptoms of cancer is used to diagnose and phase the nirundroquire tumor. This may include:

Physical examination and history
Blood chemistry studies
See general information section for details of these tests and procedures

Other tests used to diagnose neuroendocrine tumors include the following:

Full Blood Count (CBC): A process in which a sample of blood has been prepared and checked for:
Number of red blood cells, white blood cells, and platelets
Hemoglobin (protein which takes oxygen) in red blood cells
Part of blood sample made of red blood cells
Twenty-four-hour urine test: A test in which urine is collected for measuring the amount of some substances for 24 hours, such as hormones. Abnormal (more or less than normal) of the substance may be a sign of disease in the organ or tissue, which makes it a sample of urine to check whether there is carcinoma hormone made by the tumor. This test is used to diagnose cancerous syndrome.
Somatostatin receptor scintigraphy: A type of radionuclide scan that can be used to find tumors. A very small amount of radioactive octroitide (a hormone that connects the tumor) is injected into the vein and travels through the blood. Radioactive connects the octorotic tumor and a special camera that detects where radioactivity is used in the body from where the tumor occurs. This process is also called octreoid scan and SRS.
Diagnosis of disease

Diagnosis for neurorendocrin tumors in the supplement in children after surgery for removal of tumors is usually excellent. Neuroendocrine tumors that are not in the supplement are usually large or spread on other parts of the body during diagnosis and do not respond well to chemotherapy. There is a possibility of a larger tumor repetition (coming back).

treatment

Treatment for neurorendocrin tumors in children in the appendix may include:

Surgery to remove the addendum, when the tumor is small and occurs only in the appendix
Surgery to remove an appendix, lymph nodes, and part of the large intestine, when the tumor is large, it spreads in the lymph nodes, and is in the appendix.
Treatment for neurorendocrin tumors that have spread to the large intestine, pancreas, or stomach is similar to the treatment of adult high-grade neurorendroclin tumors.

See PDQ summary on adult gastrointestinal carcinoid tumor treatment for more information.

Gastrointestinal Stromal Tumors

Gastrointestinal stromal cell tumor (GIST) usually starts in cells in the stomach or intestinal wall. GISTs may be benign (not cancerous) or fatal (cancer) Childhood gifts are more common in girls, and usually appear in adolescents.

Risk Factors and Symptoms and Symptoms

GIST in children is not the same as GIST in adults. Patients should be seen in the centers which are experts in the treatment of GSTS and tumors should be tested for genetic changes. Small children have tumor with genetic changes found in small patients of adults. Risk of GIST increases with the following genetic disorders:

Carney trio
Carnie-Stratkise syndrome
Most children with GIST have stomach tumors and develop anemia due to bleeding. Symptoms and symptoms of anemia include:

feeling tired.
dizziness.
A fast or irregular heartbeat
Shortness of breath
pale skin.
A gastric or intestinal obstruction in the stomach (abdominal pain, nausea, vomiting, diarrhea, constipation and swelling of the stomach) are also signs of GIST.

Other conditions that do not cause anemia due to GIST can be similar symptoms and symptoms.

treatment

Treatment for children with tumor-containing genetic changes found in adult patients targets a treatment with a terorogenic keynes inhibitor.

Treatment for children whose tumors do not show genetic changes may include:

Surgery to remove tumor for cancer symptoms and to check nearby lymph nodes. If the cancer is in lymph nodes, lymph nodes are removed.
Waiting alert for tumors that come back or can not be removed in one place, but do not cause signs or symptoms.
Targeted therapy with trisin-keynes inhibitor

Friday, April 7, 2017

Coping with Cancer

Coping with Cancer

You may have just discovered that you have cancer. Or, there may be treatment, termination of treatment, or a friend or family afflicted with cancer. Having cancer will change your life and the lives around you. The symptoms of this disease, side effects and its treatment may cause physical changes, but it may also affect your feelings and lifestyle.

The information in this section will help you deal with many of the problems and concerns that arise when you get cancer. There are resources to help you learn about diseases and people who can help you. Please refer to the workaround on support and palliative care topics and the publication on evidence-based PDQ® summary. You know that you are not alone.


Emotions and cancer

Whether you are being treated, being treated, or whether it is friends or family members, cancer can cause a wide range of emotions. Learn tips for dealing with the many emotions that occur in cancer.




Adjust to cancer

Learn tips for talking about the changes that cancer will bring for you and your family.





Self Image & Sexuality

Cancer and its treatment can change how you feel and feel about yourself and your body. There are measures to deal with body changes and problems related to sexuality and intimacy.




Daily life

Treatment of cancer is an event that changes life for most people. It may be difficult, but there are actions to adapt to your new lifestyle.





Caregiver support

Being a carer may be stressful. Learn tips on how to care about yourself when caring for others.




Survival

Many cancer survivors say it is difficult to transition to a new way of life once treatment is over. I will examine how to adapt to new feelings and problems that arise when cancer treatment is over.




Doctor's Questions About Cancer

When you meet your doctor or other members of your medical team, please take a list of your questions.




The Study

Search for research articles to deal with cancer that includes news articles, clinical trials, blog posts, active research descriptions.

Treatment

Cancer Treatment

There are many kinds of cancer treatment. The type of treatment you have depends on the type of cancer you have and how advanced it is. Some cancer patients have only one treatment. However, most people have a combination of treatments such as surgery by chemotherapy and / or radiotherapy. Immunotherapy, targeted therapy, or hormone therapy is also available.

Clinical trials may also be your choice. A clinical trial is a study involving people. Understanding what they are and how they are functioning will help you decide if participating in a trial is a good choice for you.

There are many things to learn and think about when you need cancer treatment. It is normal to feel overwhelmed and confused. However, talking to your doctor and learning what you can do about all your treatment options including clinical trials will help you make a decision that makes you feel good. Our question to consult a doctor may help with treatment.

Types of Cancer Treatment

Methods used to treat cancer, including chemotherapy, radiotherapy, immunotherapy, and targeted therapy.




Side effect

Common side effects of cancer and cancer treatment (including causes and their prevention and management methods).




Basics of clinical trials

What clinical trials are available and important, what you should think about thinking about deciding to participate.




Find clinical trials supported by NCI

Learn how to search for clinical trials supported by NCI and identify other research research positions. This may be appropriate for you or someone you love.



List of cancer drugs

Consumer-friendly information on drugs and drug combinations used to prevent and treat cancer.




Complementary alternative medicine

The healing philosophy, approach, and treatment used in complementary alternative medicine (CAM) in cancer treatment.




Questions to ask about your treatment

Recommended questions to ask your doctor about treatment options and possible side effects of treatment.



The Study

Search news articles, clinical trials, blog posts, research articles on cancer treatment, including descriptions of active studies.

Diagnosis and scaffolding

Diagnosis and scaffolding

Cancer can cause many different symptoms. Often these symptoms are not due to cancer, but benign tumors or other problems. If you have symptoms that last for a few weeks, then your doctor should know what your symptoms are Creating a physical examination and order testing or other procedures.

If you find that you have cancer, then your doctor will order other tests or procedures to find out their stage. The phase shows your cancer range and is based on factors such as how large the tumor is and if it has spread, once your doctor knows your cancer level, she will be able to suggest treatment and discuss your diagnosis with you. Could. Understanding your cancer and knowing what to expect, you and your loved ones can help to feel more in control and cope with their diagnosis.

Learn About Cancer Symptoms

There are many different symptoms of cancer, only one doctor can tell that your symptoms are due to cancer.





Diagnosis

If you have a symptom that does not go away or the cancer diagnosis results from the screening test, the doctor should know that it is due to cancer or any other reason. Learn about the tests and procedures that help you understand the causes of your problems.



Staging


After diagnosis of cancer, the doctor needs to determine the stage. The stage tells you details about your cancer, such as how large the tumor is and if it has spread, knowing the stage, the doctor suggested the treatment options and discussed the forecast.



Prognosis

The diagnosis of the disease is how your cancer is and how many people are likely to survive. Learn about Survival Statistics and how to predict their predictions.




Questions to ask about your cancer diagnosis

These questions can help you learn more about your cancer and what you can expect next.




Research

Find articles related to cancer diagnosis and staging, which may include news stories, clinical trials, blog posts, and active study details.

Research

Diagnostics and scaffolding
Tumor cells in cockle tissue. (Credit: Antonio Villalba and María J. Carballal)

Demonstrate the need for cancer in the blood, explore researcher XOSOM
Posted: 12 July 2016
Researchers are exploring ways to gain insight into cancer and to use diagnostic tools for patients using vascals called exosomes.

Image-guided biopsy can increase the risk of high-risk tumors for diagnosis of prostate cancer
Posted: 27 January 2015
In the largest study on the date of image-guided techniques to identify suspected areas of prostate biopsy, researchers have detected high-risk prostate cancer compared to the potential of this technique, which is the absence of the current standard of absent prostate biopsy with.

NCI has established genomic data commons to identify the target of cancer molecular subtype and potential drug
Posted: December 2, 2014
NCI is establishing genomic data commons to store, analyze and distribute cancer genomics data generated by NCI and other research organizations. GDC will provide an interactive system for researchers' data with the goal of furthering the molecular diagnosis of cancer and will suggest potential therapeutic targets based on genomic information.

The Benefits Of Appearing In Many Cancer Genomes: A Perspective
Updated: 12 August 2014
Cancer is not a single unit; rather, it is more than one hundred complex and distinct diseases, most of which require the type of cancer a unique treatment strategy. TCGA researchers have developed a formal project for cross tumor analysis, which is called panic cancer. Its goal is to collect the TCGA's wealth of data in tumor types, analyze those data and analyze them, and finally, both analyzes and data available independently.

Negative side of clinical imaging
Posted: January 26, 2010
An article about calculation tomography and nuclear imaging processes and radiation performance during the risk of cancer. Several studies released in 2009 have helped to measure the risks and increasing use of these clinical imaging methods.

Questions to ask your doctor about your diagnosis

Questions to ask your doctor about your diagnosis

Credit: iStock
Learning that you can have cancer can be a shock and you feel overwhelmed at first. When you meet your doctor, you will hear a lot of information These questions can help you learn more about your cancer and what you can expect next

  • Is my cancer cancer?
  • What is the stage of my cancer?
  • Has it spread to other areas of my body?
  • Will I need further testing before treatment starts? which one?
  • Do I need an expert (s) to treat my cancer?
  • Will you have the best treatment plan for me?
  • How serious is cancer?
  • What is my chances of survival?

For questions about other topics, see our complete list of questions

Thursday, April 6, 2017

Cause And Prevention Research

Cause And Prevention Research


Aspirin to reduce cancer risk
Updated: February 23, 2017
Even a Federal Advisory Committee has supported the use of aspirin to reduce the risk of colorectal cancer in some people, but the researchers are investigating how aspirin works against cancer and whether it is for other cancers Can help reduce risk.

U.S. Cancer deaths fall, but some areas have left behind, study finds
Posted: 21 February, 2017
A study of the nationwide death rate data found that, between the 1980s and 2014, the U.S. Cancer deaths have occurred, disparities are maintained, and cancer death rate has increased greatly in 160 counties.

Changes in tobacco, types purchased in the US
Posted: January 23, 2017
According to a new study, consumption of cigarettes, small cigars and chewing tobacco in the last 15 years has decreased. This decline was partially offset by the increase in large cigars, pipe tobacco, and consumption of snuff

No safe level of smoking: Even low-intensity smokers are at increased risk of early death
Posted: 5 December 2016
Those people who used to smoke less than one cigarette a day in their lifetime, compared to those people who had 64 percent more risk than those who did not smoke.

CDC Update Recommendations on HPV Vaccine
Posted: November 14, 2016
Updating the CDC recommendations, people under the age of 15 are advised that instead of three, two doses of HPV vaccine are required.

Adolescents who did not smoked for e-cigarette
Posted: August 11, 2016
The findings of a recent study show that cigarette cigarettes are not using e-cigarettes as an alternative to conventional cigarettes, but are attracting new users of e-cigarette tobacco products.

Setting the stage for the next decade of tobacco control research
Posted: July 5, 2016
A new report from the NCI Working Group tells the recommended priorities of the Institute to help shape the future Tobacco Control Research portfolio.

Increased physical activity of low risk of 13 types of cancers
Posted: 16 May 2016
A new study of relationships between physical activity and cancer has shown that higher levels of physical activity of leisure-time were associated with the risk of developing 13 various types of cancers; Compared to at least active participants, the risk of developing seven types of cancer was less than 20 percent in most active participants.

Public Health Improvement through Increased Tobacco Regulation
Posted: 10 May 2016
NCI's Dr. Robert Crowall has discussed the release of a rule of the Food and Drug Administration which extends its regulatory authority on tobacco products to include cigars, e-cigarettes, hookah (waterpipe) tobacco.

The lack of vaccine in the targeted HPV infection in the US
Posted: March 9, 2016
Since the recommendation of HPV vaccination in the United States, human papillomavirus (HPV) types of infections targeted by the HPV vaccine have reduced by about two-thirds of teenage girls.

Mouse study points for obesity and mechanism for adding colorectal cancer risk
Posted: February 8, 2016
In coarse mice, a missing hormone can help to understand a long-term collaboration between obesity and increased risk of colorectal cancer in humans.

Antioxidants trigger tumors growth and confidence in mice
Posted: November 12, 2015
Metastatic tumor cells are particularly sensitive to oxidative stress, and increase the capacity of antioxidant supplements and metastasis.

CRISAR: Age of Genome Editing of Age
Posted: September 23, 2015
A technique for editing genes named CRISER-CS 9 has made it very easy and fast for cancer researchers to study mutations and test new therapeutic targets.

The burden of the disease of smoking: the first thought was worse than that?
Posted: 16 March 2015
According to a new study, smoking can be responsible for more deaths than before every year.

Gardasil protects vaccine against 9 additional HPV types
Posted: March 2, 2015
In a major random diagnostic test, a new human papilomavirus (HPV) vaccine effectively prevents infection and disease due to 9 HPV types, which include seven types, including cervical and other cancers - five of which are available before the HPV vaccine Did not come from- and two types due to genital warts.

Risk for smoking in the other hand, but inequalities continue
Posted: 13 February 2015
Since 1999, the exposure of second-hand smoke has fallen 50 percent, a new study has revealed, but millions of people are still regularly exposed to smoking regularly.

Study shows the increased number of cancers in HIV-positive population
Posted: February 9, 2015
In 2010, an estimated 7,760 new cancers were diagnosed in approximately 900,000 Americans who are living with HIV infection. According to the first comprehensive study in the United States, HIV-infected people are at risk of cancer similar to the general population, so more than half of these cancers were expected.

Report Offer Global Global Smoke-Tobacco Looks Comprehensive on Tobacco Use
Posted: January 7, 2015
The first report of its kind revealed that more than 300 million people worldwide use smokeless tobacco products and that they are associated with many cancers.

More than 300 million people use smokeless tobacco in at least 70 countries
Posted: 15 December 2014
For the first time on the public health and impact of tobacco smoking on public health, it is reported that in more than 70 countries, more than 300 million people use this harmful product. The title of this report is Smokeless Tobacco and Public Health: A Global Perspective.

Continue research on debates, e-cigarettes
Posted: 11 December 2014
Since they first started selling in North America in the mid-2000s, electronic cigarette has been a topic of intense debate. NCI's Dr. Michelle Bloch recently presented an update on some of the issues surrounding e-cigarette.

Human Papillomavirus (HPV) vaccine: Douglas R. Lovie, M.D. An interview with
Posted: November 20, 2014
NCI's Dr. Doug Lovie discussed the HPV vaccine, which includes the development of his efficacy, safety and next-generation vaccines.

NCI scientists have discovered protective mechanisms in the cells of progesterial patients against cancer
Posted: 2 October 2014
NCI scientists have studied the cells of patients with very rare genetic disorders, which are characteristic of aging before hard times and have discovered a new protective cellular system against cancer. They found that Hutchinson's patients with Gilford Progeria Syndrome (HGPS), who do not usually develop cancer, have a tumor protection mechanism that is mediated by BRD4.

The study of NCI has shown that overweight obesity can reduce life expectancy for 14 years
Posted: 8 July 2014
According to the results of analyzing the data collected from 20 major studies of people from three countries, people with severe obesity have died of cancer and many other causes include heart disease, stroke, diabetes, and kidney and liver disease.

Low dose of HPV vaccine is equivalent to three dose in the immune response
Posted: November 4, 2013
NCI scientists report that two doses of human papillomavirus (HPV) vaccine, which were trademarked in the form of cervix, compared to a standard three dose, similar to the two types of HPV (16 and 18) As a result of serum antibody levels.

New understanding of oral HPV infection in healthy men
Posted: July 2, 2013
Scientists report that newly acquired oral HPV infections in healthy men are uncommon and when presently, they go away within a year.

The possibility of large studies to build a genetic risk forecast model
Posted: March 4, 2013
NCI scientists have developed a new paradigm to assess genetic risk prediction in general diseases, such as prostate cancer. This concept of genetic risk prediction is based on polygenic analysis - a study of a group of common DNA sequences, called single nucleotide polyamorphism (SNP), each of which contributed very small amounts in the risk of overall disease, but Having a strong impact on grouping together

DNA breaks quickly in the replication process associated with B cell cancer.
Posted: 24 January 2013
Research by scientists at NCI has identified a new class DNA site in cells that break the initial in the replication process. They found that these break sites are often related to damaged damage in B cell cancers, such as spreading BB cell lymphoma.

NIH studies estimate physical activity of holiday time that is 4.5 years longer than life
Posted: November 6, 2012
According to a study by a team of researchers led by NCI, physical activity of leisure-time is linked to life expectancy for a long time, even at a relatively low level of activity and regardless of body weight. It was found in the study that the life benefits of the people who took part in physical activity of leisure-time were 5.5 years of life, which appeared on November 6, 2012 in Plois Medicine.

U.S. Men's growing anus related to HIV infection associated with cancer rates
Posted: 5 October 2012
According to the new research by NCI, human immunodeficiency virus (HIV) contributes significantly to anal pandemic epidemic in men, but there is no number of women in the United States. The chart shows the overall rate of anal cancer in the general population with the dashed line shown with HIV infected people.

Dr. Diet and Cancer Conversation with Walter Willet
Posted: August 7, 2012
Dr. Walter Willlet, President of the Nutrition Department at the Harvard School of Public Health, answers questions about how ideas have developed about the dangers of diet and cancer.

Childhood CT spoons in the NIH study reveal that later life is linked to leukemia and brain cancer.
Posted: June 7, 2012
Children and young adults scanned, often scanned, often used in diagnostic tools by scanned temguri (CT), increased their risk of leukemia and brain tumors in a decade after their first scan is.

From the beginning of the decade of the 1990s, the country's report continues to decline in the mortality rate of cancer; The feature highlights the cancer associated with excess weight and lack of sufficient physical activity.
Posted: 28 March 2012
According to the National Annual Report on Cancer Status of 1975-2008, the rate of death of all cancers combined for men, women and children in the United States between the years of 2004 and 2008, continued to decline in the United States. The overall rate of the new cancer diagnosis, also known as the phenomenon, is due to a reduction of average 0.6 percent per year between men and women between 2004 and 2008. The incidence of total cancer incidence of women between 2006 and 1998 has declined by 0.5 percent from 1998 to 2006. Through 2008.

The new report highlighted the epidemic of tobacco and global health disparities
Posted: March 21, 2012
A new group of 11 global health studies focuses on the burden of tobacco related inequalities in low-and-middle income countries and found that socio-economic inequality is linked to the increase in tobacco use, the second hand is related to smoking and tobacco related Cancer and disease among the deprived population in Asia, Latin America and Africa.

Second HPV vaccine shows initial positive results
Updated: December 2, 2011
According to Lancet, June 30, 2007, Commentary Carrier® was 90% effective against two types of human papillomavirus (HPV), which could cause cervical cancer.

Exposure to Adding Obesity and Cancer Risk
Posted: November 15, 2011
Biological Process Is there an intermediary relationship between the excess body fat and the risk of increased cancer? Researchers are investigating that hormones, swelling, signaling molecules and other biological agents can play a role in the progress of cancer.

To detect cancer biology in adolescents and young adults
Posted: July 26, 2011
Evidence shows that some teenage and young adult can have genetic and biological characteristics in cancer, to identify possible clinical goals, researchers are trying to better understand the biology of these cancers.

Dr. Talk about cell phone use and cancer risk about Martha Linet
Posted: June 28, 2011
Head of radiation epidemiology branch in NCI's Cancer Pathology and Genetics Division, Dr. Martha Lennet responds to questions about ongoing research to study mobile phone usage and risk of cancer.

Despite initial suspicion, HPV vaccine proved effective
Posted: May 31, 2011
There are special symptoms in human papillomirus responsible for almost all cases of cervical cancer, which enable the vaccine to be particularly useful for vaccine development. This article describes the research that went into developing two vaccines approved by the FDA.

Reduction of radiation exposure during regular medical imaging
Posted: March 8, 2011
Risk of radiation has increased dramatically from medical imaging in the United States. NCI and many partner organizations sponsored a 2011 conference to boost efforts to reduce radiation exposure from medical imaging.